Admedus (AHZ) Short Interest
Admedus (ASX:AHZ) had 0.02% of shares reported as short positions as of 27 Apr 2020, representing 962 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Admedus
Admedus is a healthcare company specializing in the development and commercialization of medical technologies. It focuses on providing innovative solutions in the field of biotechnology, particularly in regenerative medicine and tissue engineering.
Short position
Admedus (ASX:AHZ) has 0.02% of its shares on issue reported as short positions as of 27 Apr 2020, or about 962 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.30% in August 2016. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AHZ intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Admedus
Be the first to discuss AHZ
Start a research thread or post the first pulse update